Cancer researchers have always been ahead of the curve when it comes to adoption of platforms that lead to better understanding of the molecular nature of disease, identify critical molecular differences between tumor and normal samples, and accelerate identification of drug targets and diagnostic or prognostic markers. Through its software applications IPA and Variant Analysis, Ingenuity Systems has been supporting leading edge cancer researchers by keeping pace with cancer-related findings published in the biomedical literature, and integrating databases of high quality, relevant, gene to disease associations into the Ingenuity Knowledge Base.
As of January 2013, Ingenuity applications have supported research published in over 2200 peer-reviewed original research articles, focused on Cancer Research applications such as:
- Biomarker Discovery
- Target Identification
- Anti-neoplastic Drug Mechanism of Action
Ingenuity applications are also keeping up with the rapidly evolving field of molecular oncology, and provide a greatly improved workflow for cancer researchers to proficiently handle large-scale data generated from many platforms including:
- NGS for Variant Analysis